News

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma

15-11-2012

US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top